Search bioRxivSearch

Biology subjects

Nijhout, H. F.

Publications and source records attributed to Nijhout, H. F..

2 recordsLinked to original sources

Step-wise evolution of temperature-mediated phenotypic plasticity in eyespot size across nymphalid butterflies

There are two disparate views regarding phenotypic plasticity. One regards plasticity as a derived adaptation to help organisms survive in variable environments1, 2 while the other views plasticity as the outcome of flexible, non-canalized, developmental processes, ancestrally present in most organisms, that helps them colonize or adapt to novel environments3-5 e.g., a pre-adaptation. Both views of plasticity currently lack a rigorous, mechanistic examination of ancestral and derived states and direction of change2. Here we show that the origin of phenotypic plasticity in eyespot size in response to environmental temperature observed in Bicyclus anynana butterflies is a derived adaptation of this lineage. Eyespot size is regulated by temperature-mediated changes in levels of a steroid hormone, 20E, that affects proliferation of eyespot central cells expressing the 20E receptor (EcR)6, 7. By estimating the origin of the known physiological and molecular components of eyespot size plasticity in a comparative framework, we showed that 20E titer plasticity in response to temperature is a pre-adaptation shared by all butterfly species examined, whereas the origin of expression of EcR in eyespot centers, and the origin of eyespot sensitivity to the hormone-receptor complex are both derived traits found only in a subset of species with eyespots. The presence of all three molecular components required to produce a plastic response is only observed in B. anynana. This gradual, step-wise, physiological/molecular response to temperature is a likely adaptation to temperature variation experienced across wet and dry seasons in the habitat of this species. This work supports, thus, the first view of plasticity as a derived adaptation.

evolutionary biology

The Case for Pyriproxyfen as a Potential Cause for Microcephaly; From Biology to Epidemiology

The Zika virus has been the primary suspect in the large increase in incidence of microcephaly in 2015-6 in Brazil. However its role is not confirmed despite individual cases in which viral infections were found in neural tissue. Recently, the disparity between the incidences in different geographic locations has led to questions about the viruss role. Here we consider the alternative possibility that the use of the insecticide pyriproxyfen for control of mosquito populations in Brazilian drinking water is the primary cause. Pyriproxifen is a juvenile hormone analog which has been shown to correspond in mammals to a number of fat soluble regulatory molecules including retinoic acid, a metabolite of vitamin A, with which it has cross-reactivity and whose application during development has been shown to cause microcephaly. Methoprene, another juvenile hormone analog that was approved as an insecticide based upon tests performed in the 1970s, has metabolites that bind to the mammalian retinoid X receptor, and has been shown to cause developmental disorders in mammals. Isotretinoin is another example of a retinoid causing microcephaly in human babies via maternal exposure and activation of the retinoid X receptor in developing fetuses. Moreover, tests of pyriproxyfen by the manufacturer, Sumitomo, widely quoted as giving no evidence for developmental toxicity, actually found some evidence for such an effect, including low brain mass and arhinencephaly--incomplete formation of the anterior cerebral hemispheres--in exposed rat pups. Finally, the pyriproxyfen use in Brazil is unprecedented-- it has never before been applied to a water supply on such a scale. Claims that it is not being used in Recife, the epicenter of microcephaly cases, do not distinguish the metropolitan area of Recife, where it is widely used, and the municipality, and have not been adequately confirmed. Given this combination of information about molecular mechanisms and toxicological evidence, we strongly recommend that the use of pyriproxyfen in Brazil be suspended until the potential causal link to microcephaly is investigated further.

epidemiology